Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorIstanbul University - Cerrahpasa

About this trial

The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients. The main questions it aims to answer are:

* Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of psychological distress? * Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of reintegration into normal life?

Researchers will compare Acceptance and Commitment Therapy-Based Intervention for Oncology Patients (ACT) to Psychoeducation for Oncology Patients and routine care (with no specific intervention) to see if Acceptance and Commitment Therapy-Based Intervention for Oncology Patients is effective in psychological distress and reintegration into normal living.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years of age or older,

Being able to read and write,

Receiving oncologic treatment,

Being diagnosed with breast cancer,

Disqualifiers

Having serious psychiatric or cognitive impairments that limit adherence to group sessions,

Having a physical disability that may make it difficult to participate in group sessions,

Failure to attend sessions regularly and absenteeism,

Currently being in a psychoeducation/psychotherapy group

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acceptance and Commitment Therapy-Based Intervention for Oncology Patients

    Behavioral

    An intervention program was prepared for oncology patients aiming to reduce psychological distress and increase participation in normal life.

  • Psychoeducation for Oncology Patients

    Behavioral

    A program was prepared to support oncology patients in physical and psychological symptom management.

Treatment groups

75 Participants
are divided into 3 treatment groups
Group A: Acceptance and Commitment Therapy Based Intervention for Oncology PatientsExperimental treatment 1 intervention
Group B: Psychoeducation for Oncology PatientsActive comparator 1 intervention
Group C: Routine CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

The Distress Thermometer (DT)

The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

Time frame
1 day before intervention start
2

The Distress Thermometer (DT)

The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

Time frame
through study completion, an average of 1 year
3

The Distress Thermometer (DT)

The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

Time frame
one month after the end of the interventions

Secondary outcomes

1

Reintegration to Normal Living Index (RNLI)

The Reintegration to Normal Living Index (RNLI) has two sub-dimensions. These are: daily functions and self-perceptions. The scale is scored on a five-point Likert scale: Strongly Disagree (1 point), Disagree (2 points), Undecided (3 points), Agree (4 points) and Strongly Agree (5 points). Scores that can be obtained from the scale vary between 11 and 55. A high score on the scale indicates a better level of participation in normal life.

Time frame
1 day before intervention start
2

Reintegration to Normal Living Index (RNLI)

The Reintegration to Normal Living Index (RNLI) has two sub-dimensions. These are: daily functions and self-perceptions. The scale is scored on a five-point Likert scale: Strongly Disagree (1 point), Disagree (2 points), Undecided (3 points), Agree (4 points) and Strongly Agree (5 points). Scores that can be obtained from the scale vary between 11 and 55. A high score on the scale indicates a better level of participation in normal life.

Time frame
through study completion, an average of 1 year
3

Reintegration to Normal Living Index (RNLI)

The Reintegration to Normal Living Index (RNLI) has two sub-dimensions. These are: daily functions and self-perceptions. The scale is scored on a five-point Likert scale: Strongly Disagree (1 point), Disagree (2 points), Undecided (3 points), Agree (4 points) and Strongly Agree (5 points). Scores that can be obtained from the scale vary between 11 and 55. A high score on the scale indicates a better level of participation in normal life.

Time frame
one month after the end of the interventions

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.